Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease
A completed study evaluating the construct validity and responsiveness of the EQ-5D-3L health-status instrument in patients with rheumatic d…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Integral Single-cell Landscape of Immunological Hallmarks for Ankylosing Spondylitis [NA]
This completed study maps the integral single-cell landscape of immunological hallmarks in ankylosing spondylitis to understand disease immu…
-
EMA approval · 2025-03-03EMA Authorised: Nepexto (etanercept) — Biosimilar Collaborations Ireland Limited
EMA authorised Nepexto, a biosimilar of etanercept, developed by Biosimilar Collaborations Ireland Limited, for several inflammatory arthrit…
-
FDA approval · 2025-02-27FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Diclofenac Sodium/Misoprostol (Diclofenac-Sodium-Misoprostol) from Micro Labs Limited.
-
FDA approval · 2025-02-26FDA Approved: CELECOXIB — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for Celecoxib (celecoxib), authorizing a generic version under the ANDA pathway. The ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-24FDA Approved: INDOMETHACIN — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's original application for Indomethacin, authorizing a generic version of the NSAID with the same…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Examining the Effect of Home-Based Exercise on Disease Activity in Patients With Ankylosing Spondylitis Using SIRI and SII [NA]
This update reports the completion of a clinical trial examining the effect of home-based exercise on disease activity in ankylosing spondyl…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS
A longitudinal observational study evaluating whether movement guidance and smartwatch-based mobility tracking improve outcomes in axial spo…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis [Phase 4]
Phase 4 trial update evaluating a combination of an IL-17 inhibitor with a TNFα inhibitor for ankylosing spondylitis; the study is currently…
-
FDA approval · 2025-02-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen (ANDA074190) from Hikma Pharmaceuticals USA Inc., resulting in an updated approval of t…
-
CLINICAL_TRIALS withdrawal · 2025-02-13Clinical Trial Update: Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis
The trial evaluating enhanced clinics for patients with ankylosing spondylitis and psoriatic arthritis has been withdrawn.
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis
A completed analysis of birth outcomes among Swedish, Danish, and Finnish women exposed to Remicade (infliximab) during pregnancy across inf…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: OTIS Cimzia Pregnancy Registry
This clinical trial registry update describes the OTIS Cimzia Pregnancy Registry sponsored by UC San Diego. It tracks pregnancy outcomes for…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Biomarkers in Inflammatory Rheumatic Diseases Diagnosis
A clinical trial update from Universidade Nova de Lisboa focusing on biomarkers for diagnosing inflammatory rheumatic diseases, currently re…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: The Effects of Aerobic Exercise in Patients With Ankylosing Spondylitis [NA]
A completed clinical trial investigated the effects of aerobic exercise on disease activity in patients with ankylosing spondylitis.
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Registry study evaluating patient-reported outcomes, dosing patterns, and safety of Vunakizumab in several rheumatic diseases; recruitment h…
-
FDA approval · 2024-12-19FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA supplemental approval for Aurobindo Pharma Limited's generic celecoxib.
-
FDA approval · 2024-12-18FDA Approved: IDACIO — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for IDACIO (adalimumab-aacf) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
An observational study evaluating the safety and efficacy of Remsima (infliximab biosimilar) in patients with Ankylosing Spondylitis was ter…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil
A real-world study evaluating tuberculosis incidence in patients with ankylosing spondylitis, psoriatic arthritis, or plaque psoriasis treat…
-
FDA approval · 2024-11-21FDA Approved: DICLOFENAC SODIUM AND MISOPROSTOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for diclofenac sodium and misoprostol from Mylan Pharmaceuticals Inc., updating the product's la…
-
FDA approval · 2024-11-21FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
FDA approved a supplemental application for Tolmetin Sodium (generic tolmetin) from Atland Pharmaceuticals, LLC.
-
FDA approval · 2024-11-21FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for MELOXICAM from Zydus Pharmaceuticals USA Inc., as part of an ANDA, indicating approval of an…
-
FDA approval · 2024-11-21FDA Approved: INDOMETHACIN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for indomethacin submitted by Chartwell RX, LLC. This action represents an approved supplement t…